Critical Care

  • The current state of tobacco cessation treatment
    Humberto K. Choi, MD, FCCP, Jorge Ataucuri-Vargas, MD, Charlie Lin, MD and Amanda Singrey, PharmD, BCACP, CTTS
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 393-404; DOI: https://doi.org/10.3949/ccjm.88a.20099

    Behavioral interventions and pharmacotherapy increase success rates. Alternative treatments should not replace or delay the use of known effective therapies.

  • Evolving distal signs
    Zackary D. Goff, MD, Sandra E. Zaeh, MD, MS, Michael K. Poku, MD, John N. Aucott, MD and Allan C. Gelber, MD
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 310-312; DOI: https://doi.org/10.3949/ccjm.88a.20126

    The patient’s evolving signs and symptoms prompted a reconsideration of his diagnosis.

  • Famous and not-so-famous physical findings in infectious endocarditis: A look back
    Adam J. Brown, MD
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 316-318; DOI: https://doi.org/10.3949/ccjm.88a.21033

    It is difficult to find a disease more emblematic of the practice of internal medicine.

  • COVID-19: An unwelcome guest that won’t leave
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 254-255; DOI: https://doi.org/10.3949/ccjm.88b.05021

    Long-lasting economic and societal effects, and lingering post-infection symptoms.

  • Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’
    Susan Vehar, MD, Marina Boushra, MD, Prince Ntiamoah, MD and Michelle Biehl, MD, MS
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 267-272; DOI: https://doi.org/10.3949/ccjm.88a.21010

    An estimated 10% of COVID-19 survivors continue to experience symptoms weeks to months after symptoms appear.

  • What is causing the ‘long-hauler’ phenomenon after COVID-19?
    Leonard H. Sigal, MD, FACP, FACR, MACR
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 273-278; DOI: https://doi.org/10.3949/ccjm.88a.21009

    We are still early in our understanding of COVID-19 and its many manifestations.

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

  • In Reply: COVID-19 coagulopathy
    Simon R. Mucha, MD, Siddharth Dugar, MD, Keith McCrae, MD, Douglas Joseph, DO, John Bartholomew, MD, Gretchen L. Sacha, PharmD, RPh, BCCCP and Michael Militello, PharmD, RPh, BCPS
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/cjm.87c.12002

    An attempt to balance the potential risks and benefits of intensified prophylaxis.

  • Dexamethasone or hydrocortisone in COVID-19?
    Chia Siang Kow, and Syed Shahzad Hasan,
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 715; DOI: https://doi.org/10.3949/ccjm.87c.12005

    Dexamethasone should be favored over hydrocortisone.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

Pages